|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-12-14
|
|
pubmed:abstractText |
It is known that the efficacy of thrombolytic therapy in ST-segment elevation myocardial infarction (STEMI) is highly time dependent with the best efficacy when given within the so-called golden hour. This analysis from the On-TIME 2 trial evaluated the efficacy of triple antiplatelet therapy on initial patency and ST-segment resolution (STR) in relation to time from symptom onset to first medical contact.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
pubmed-author:BoersmaEricE,
pubmed-author:DillThorstenT,
pubmed-author:GosselinkA T MarcelAT,
pubmed-author:HammChristianC,
pubmed-author:HeestermansTonT,
pubmed-author:KochmanWaclavW,
pubmed-author:KoopmansPetra CPC,
pubmed-author:MosterdArendA,
pubmed-author:StellaPieter RPR,
pubmed-author:ZijlstraFelixF,
pubmed-author:ten BergJurriën MJM,
pubmed-author:van 't HofArnoud W JAW,
pubmed-author:van HouwelingenGertG,
pubmed-author:van WerkumJochem WJW,
pubmed-author:van ZoelenArthur BAB
|
|
pubmed:copyrightInfo |
Copyright © 2010 Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1079-84
|
|
pubmed:meshHeading |
pubmed-meshheading:21146661-Adult,
pubmed-meshheading:21146661-Aged,
pubmed-meshheading:21146661-Aged, 80 and over,
pubmed-meshheading:21146661-Dose-Response Relationship, Drug,
pubmed-meshheading:21146661-Drug Therapy, Combination,
pubmed-meshheading:21146661-Emergency Medical Services,
pubmed-meshheading:21146661-Female,
pubmed-meshheading:21146661-Follow-Up Studies,
pubmed-meshheading:21146661-Humans,
pubmed-meshheading:21146661-Infusions, Intravenous,
pubmed-meshheading:21146661-Male,
pubmed-meshheading:21146661-Middle Aged,
pubmed-meshheading:21146661-Myocardial Infarction,
pubmed-meshheading:21146661-Platelet Aggregation Inhibitors,
pubmed-meshheading:21146661-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:21146661-Time Factors,
pubmed-meshheading:21146661-Treatment Outcome,
pubmed-meshheading:21146661-Tyrosine,
pubmed-meshheading:21146661-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
|
|
pubmed:affiliation |
Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
